Integrity.  Clarity.  Accountability.  Transparency.  Practice.

Ethics Is the Foundation. Not the Fine Print

JYSTA holds itself to the same standards it asks of the clinicians it serves. Every decision, every partnership, and every program is governed by a commitment to transparency, accountability, and the responsible growth of Schema Therapy across the Americas.

Trust Is Earned in the Details

Schema Therapy is built on a simple conviction: that people deserve to have their needs met with honesty, care, and consistency. That conviction does not stop at the therapy room door.

Every training standard JYSTA sets, every partnership it enters, every certification it approves carries the weight of that commitment. The Ethics and Regulatory Affairs Committee exists to make sure the association lives up to it. Not in principle. In practice. In the specific, unglamorous work of governance that determines whether an organization deserves the trust it asks for.

The field Jeffrey Young built deserves nothing less.

OUR COMMITMENT

Schema Therapy Deserves Better Than Good Intentions

Good ethics are not passive. They require structure, accountability, and people willing to do the unglamorous work of getting governance right. That is what this committee exists to do.

The People Who Hold the Line

Take a peek inside our Wonderworld

ERAC members were selected for their clinical depth, ethical judgment, and commitment to the responsible growth of Schema Therapy. They do not hold ceremonial roles. They do the work.

Nicholas Scheidt, MS, PsyD, AADP, NRHSP

Chair

Nicholas brings the rare combination of clinical expertise and regulatory knowledge required to lead a committee responsible for setting the ethical standards of a growing international association.

Evangelia (Litsa) Anthis, CPhycol.

Committee Member

Litsa contributes a rigorous grounding in psychological ethics and a cross-cultural perspective that strengthens the committee’s reach and relevance across diverse professional communities.

Teresa Reitz, LCSW

Committee Member

Teresa brings deep clinical experience and a practitioner’s understanding of the real-world ethical challenges that Schema Therapy clinicians face at every stage of their careers.

Every seat on this committee is filled with intention. We are not done yet.

The work of building a truly representative committee is ongoing. We are appointing additional members deliberately, not quickly, because the communities Schema Therapy serves deserve governance that actually reflects them.

Governance: How We Hold Ourselves Accountable

Every member of the JYSTA Board of Directors reviewed, signed, and submitted this policy to the Internal Revenue Service as part of the association’s formal governance filings. It is not an internal document. It is a public commitment.

The Board of Directors welcomes the counsel of the Ethics and Regulatory Affairs Committee. ERAC operates with the independence required to do its work well, and the Board treats its guidance, recommendations, and concerns as essential input into the governance of JYSTA. When ERAC speaks on matters of ethics, regulatory compliance, or accountability, the Board listens, weighs, and acts.

Presentation Conflict of Interest / AI Disclosure Questionnaire

Please indicate yes/no if any of the following are applicable:

1

Do you have any financial interests or relationships with companies that produce products, services, or devices discussed in this presentation? (e.g., stocks, grants, consulting fees)

☐ Yes    ☐ No
2

Have you received funding, travel support, or honoraria from a company whose product is relevant to this topic?

☐ Yes    ☐ No
3

Do you hold any copyrights, patents, trademarks, or intellectual property relevant to the subject matter?

☐ Yes    ☐ No
4

Are you involved in any leadership roles, such as serving on the board of directors or as a consultant for an organization with a stake in this presentation?

☐ Yes    ☐ No
5

Do any of your family members have financial ties to entities relevant to this topic?

☐ Yes    ☐ No

🤖 AI Disclosure

6

Was Generative AI used (e.g., ChatGPT, Claude, Gemini, Midjourney) in the creation of this presentation?

☐ Yes    ☐ No
7

If yes, what specific AI tools were used and for what purpose? (e.g., brainstorming, drafting text, creating slides, data analysis, image generation)

Name of AI Model used:

8

Did AI generate substantial parts of the script, content, or visuals?

☐ Yes    ☐ No
9

AI was used primarily for editing/structuring?

☐ Yes    ☐ No
10

Was all AI-generated content verified for accuracy, ethical application/standards, or biases?

☐ Yes    ☐ No

If yes to any of the above:

Please describe the nature of the relationship and the company/organization involved:

ERAC Review

Recommendation:

☐ Accepted ☐ Not Accepted ☐ Returned for Revision ☐ Referred to BOD ☐ Other: ___________________